Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab and Bevacizumab in Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05377034
What this trial is testing

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

Who this might be right for
Locally Advanced Hepatocellular Carcinoma
National Cancer Centre, Singapore 100
Not applicableLooking for participantsNCT07365930
What this trial is testing

NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 350
Not applicableActive Not RecruitingNCT06117891
What this trial is testing

An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

Who this might be right for
Unresectable Hepatocellular Carcinoma
Bayer 300
Very early researchActive Not RecruitingNCT04857684
What this trial is testing

SBRT + Atezolizumab + Bevacizumab in Resectable HCC

Who this might be right for
Hepatocellular CarcinomaResectable Hepatocellular Carcinoma
Massachusetts General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07010497
What this trial is testing

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Asan Medical Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT07246668
What this trial is testing

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsCarcinoma+1 more
Yonsei University 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07774247
What this trial is testing

Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
CHA University 51